Prognostic value of lymph node ratio and extramural vascular invasion on survival for patients undergoing curative colon cancer resection

British Journal of Cancer

Volumn 113, Issue 2, 2015, Pages 212-219

  Parnaby, C N ^a   Scott, N W ^b   Ramsay, G ^a   Mackay, C ^a   Samuel, L ^a   Murray, G I ^a   Loudon, M A ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLON CANCER; COLON RESECTION; COLONOSCOPY; DATA BASE; DISEASE FREE SURVIVAL; ELECTIVE SURGERY; EMERGENCY SURGERY; EXTRAMURAL VASCULAR INVASION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TUMOR INVASION; VASCULAR TUMOR; VERY ELDERLY; COLONIC NEOPLASMS; LYMPH NODE; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY;

AGED; COLONIC NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 84937072979     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.211     Document Type: Article

References (27)

1. Baxter NN, Ricciardi R, Simunovic M, Urbach DR, Virnig BA (2010) An evaluation of the relationship between lymph node number and staging in pT3 colon cancer using population-based data. Dis Colon Rectum 53: 65-70.
2. Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG (2005) Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23: 8706-8712.
3. Betge J, Pollheimer MJ, Lindtner RA, Komprat P, Schlemmer A, Rehak P, Vieth M, Hoefler G, Langner C (2012) Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer 118: 628-638.
4. Bhangu A, Fitzgerald JEF, Slesser A, Northover JM, Faiz O, Tekkis P (2013) Prognostic significance of extramural vascular invasion in T4 rectal cancer. Colorectal Dis 15(11): e665-e671.
5. Bui L, Rempel E, Reeson D, Simunovic M (2006) Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study. J Surg Oncol 93(6): 439-445.
6. Chen SL, Bilchik AJ (2006) More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg 244(4): 602-610.
7. Choi HK, Law WL, Poon JT (2010) The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes. BMC Cancer 10: 267.
8. Cianchi F, Palomba A, Boddi V, Messerini L, Pucciani F, Perigli G, Bechi P, Cortesini C (2002) Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg 26(3): 384-389.
9. Courtney ED, West NJ, Kaur C, Ho J, Kalber B, Hagger R, Finlayson C, Leicester RJ (2009) Extramural vascular invasion is an adverse prognostic indicator of survival in patients with colorectal cancer. Colorectal Dis 11: 150-156.
10. de Gramont A, Van Cutsem E, Schmoll HJ, Tabernero J, Clarke S, Moore MJ, Cunningham D, Cartwright TH, Hecht JR, Rivera F, Im SA, Bodoky G, Salazar R, Maindrault-Goebel F, Shacham-Shmueli E, Bajetta E, Makrutzki M, Shang A, Andre T, Hoff PM (2012) Bevacizumab plus oxaliplatin as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial. Lancet Oncol 13: 1225-1233.
11. Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S (2009) Standardized surgery for colonic cancer: complete mesocolic excision and central ligation-technical notes and outcome. Colorectal Dis 11: 354-365.
12. International Agency for Research on Cancer (2008) GLOBOCAN: Cancer Incidence, Mortality and Prevalence Worldwide (2008 Estimates). World Health Organization: Lyon, France.
13. Lykke J, Roikjaer O, Jess P. Danish Colorectal Cancer Group (2013) The relation between lymph node status and survival in stage I-III colon cancer: results from a prospective nationwide cohort study. Colorectal Dis 15: 559-565.
14. Morris M, Platell C, de Boer B, McCaul K, Iacopetta B (2006) Populationbased study of prognostic factors in stage II colonic cancer. Br J Surg 93: 866-871.
15. Moug SJ, McColl G, Lloyd SM, Wilson G, Saldanha JD, Diament RH (2011) Comparison of positive lymph node ratio with an inflammation-based prognostic score in colorectal cancer. Br J Surg 98: 282-286.
16. O'Shea A, Aly O, Parnaby CN, Loudon MA, Samuel LM, Murray GI (2014) Increased lymph node yield in colorectal cancer is not necessarily associated with greater number of lymph node positive cancers. PLoS One 9: e104991.
17. Quirke P, Morris E (2007) Reporting colorectal cancer. Histopathology 50: 103-112.
18. Rosenberg R, Engel J, Bruns C, Hettland W, Hermes N, Jauch KW, Kopp R, Putterich E, Ruppert R, Schuster T, Friess H, Hulzel D (2010) The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients. Ann Surg 251: 1070-1078.
19. Rosenberg R, Friederichs J, Schuster T, Gertler R, Maak M, Becker K, Grebner A, Ulm K, Hofler H, Nekarda H, Siewert JR (2008) Prognosis of patients with colorectal cancer is associated with lymph node ratio. Ann Surg 248: 1067-1073.
20. Schiffmann L, Eiken AK, Gock M, Klar E (2013) Is the lymph node ratio superior to the Union for International Cancer Control (UICC) TNM in prognosis of colon cancer. World J Surg Oncol 11: 79.
21. SCOT-Short Course Oncology Therapy (2007) SCOT-Short Course Oncology Therapy: a study of adjuvant chemotherapy in colorectal cancer by the CACTUS and QUASAR 3 groups. Clinical trial. gov number NCT00749450.
22. Sjo OH, Merok MA, Svindland A, Nesbakken A (2012) Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer. Dis Colon Rectum 55: 307-315.
23. Sobin LH, Wittekind Ch (eds): (1997) TNM Classification of Malignant Tumours, 5th edn. Wiley-Liss: New York, NY, USA
24. Sternberg A, Sibirsky O, Cohen D, Blemenson LE, Rodriguez-Bigas MA, Petrelli NJ (1999) New approach to the substaging of node-positive colorectal adenocarcinoma. Ann Surg Oncol 6: 161-165.
25. Ueno H, Mochizuki H, Akagi Y, Kusumi T, Yamada K, Ikegami M, Kawachi H, Kameoka S, Ohkura Y, Masaki T, Kushima R, Takahashi K, Ajioka Y, Hase K, Ochiai A, Wada R, Iwaya K, Shimazaki H, Nakamura T, Sugihara K (2012) Optimal colorectal cancer staging criteria in TNM classification. J Clin Oncol 30: 1519-1526.
26. Wang J, Hassett JM, Dayton MT, Kulaylat MN (2008) Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol 15: 1600-1608.
27. Williams GT, Quirke P, Shepherd NA (2007) Standards and Datasets for Reporting Cancers. Dataset for Colorectal Cancer, 2nd edn. Royal College of Pathologists: London, UK.